Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo J Noordman

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Robotic Surgery|May 19, 2026
Robot-assisted versus laparoscopic total gastrectomy: a western high-volume tertiary referral center experienceJonas Sanberg, Bo J Noordman, Mats Lindblad, et al.
BMJ Open|June 10, 2022
Nissen-Sleeve procedure versus laparoscopic Roux-en-Y gastric bypass in patients with morbid obesity and gastro-oesophageal reflux disease: protocol for a non-inferiority randomised trial (GINSBY)Judith W H 't Hart, Bo J Noordman, Laser U Biter, et al.
Annals of Surgical Oncology|November 7, 2019
External Validation of Pretreatment Pathological Tumor Extent in Patients with Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal CancerSebastian Brinkmann, Bo J Noordman, Arnulf H Hölscher, et al.
Annals of Surgery|June 13, 2019
Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysisBen M Eyck, Barbera D Onstenk, Bo J Noordman, et al.
European Journal of Medical Genetics|January 11, 2020
Development of esophageal squamous cell cancer in patients with FAMMM syndrome: Two clinical reportsBerend J van der Wilk, Bo J Noordman, Peggy N Atmodimedjo, et al.
The British Journal of Surgery|May 9, 2024
Intraperitoneal chemotherapy for peritoneal metastases of gastric origin: a systematic review and meta-analysisNiels A D Guchelaar, Kazem Nasserinejad, Bianca Mostert, et al.
Annals of Surgical Oncology|August 16, 2023
Characteristics Predicting Short-Term and Long-Term Health-Related Quality of Life in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy and EsophagectomyBerend J van der Wilk, Ben M Eyck, Bo J Noordman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 24, 2025
The dilemma of ypN3 esophageal cancerPim B Olthof, Bo J Noordman, Sofie P G Henckens, et al.
The Lancet Regional Health. Europe|February 5, 2024
Long-term effect of sleeve gastrectomy vs Roux-en-Y gastric bypass in people living with severe obesity: a phase III multicentre randomised controlled trial (SleeveBypass)L Ulas Biter, Judith Wh 't Hart, Bo J Noordman, et al.
Annals of Surgery|August 14, 2024
Prolonged Time to Surgery in Patients with Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal CancerHidde C G Overtoom, Ben M Eyck, Berend J van der Wilk, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Robotic Surgery|May 19, 2026
Robot-assisted versus laparoscopic total gastrectomy: a western high-volume tertiary referral center experienceJonas Sanberg, Bo J Noordman, Mats Lindblad, et al.
BMJ Open|June 10, 2022
Nissen-Sleeve procedure versus laparoscopic Roux-en-Y gastric bypass in patients with morbid obesity and gastro-oesophageal reflux disease: protocol for a non-inferiority randomised trial (GINSBY)Judith W H 't Hart, Bo J Noordman, Laser U Biter, et al.
Annals of Surgical Oncology|November 7, 2019
External Validation of Pretreatment Pathological Tumor Extent in Patients with Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal CancerSebastian Brinkmann, Bo J Noordman, Arnulf H Hölscher, et al.
Annals of Surgery|June 13, 2019
Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysisBen M Eyck, Barbera D Onstenk, Bo J Noordman, et al.
European Journal of Medical Genetics|January 11, 2020
Development of esophageal squamous cell cancer in patients with FAMMM syndrome: Two clinical reportsBerend J van der Wilk, Bo J Noordman, Peggy N Atmodimedjo, et al.
The British Journal of Surgery|May 9, 2024
Intraperitoneal chemotherapy for peritoneal metastases of gastric origin: a systematic review and meta-analysisNiels A D Guchelaar, Kazem Nasserinejad, Bianca Mostert, et al.
Annals of Surgical Oncology|August 16, 2023
Characteristics Predicting Short-Term and Long-Term Health-Related Quality of Life in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy and EsophagectomyBerend J van der Wilk, Ben M Eyck, Bo J Noordman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 24, 2025
The dilemma of ypN3 esophageal cancerPim B Olthof, Bo J Noordman, Sofie P G Henckens, et al.
The Lancet Regional Health. Europe|February 5, 2024
Long-term effect of sleeve gastrectomy vs Roux-en-Y gastric bypass in people living with severe obesity: a phase III multicentre randomised controlled trial (SleeveBypass)L Ulas Biter, Judith Wh 't Hart, Bo J Noordman, et al.
Annals of Surgery|August 14, 2024
Prolonged Time to Surgery in Patients with Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal CancerHidde C G Overtoom, Ben M Eyck, Berend J van der Wilk, et al.
Pageof 2